.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Sublingual immunotherapy benefits patients by addressing the immune system directly. Consequently, the ERAPP real-world study evaluated how these products perform in daily practice. This prospective research followed nearly 5000 participants in France for up to 15 months. Therefore, clinicians can now rely on robust data regarding patient-perceived outcomes.
The study results showed that over 80% of participants achieved clinically relevant benefits. Specifically, 83.8% of children and 84% of adults reached a Patient Benefit Index (PBI) score of at least 1. This high success rate indicates that the treatment met patient expectations effectively. Moreover, researchers noted significant improvements in rhinitis severity and overall symptom burden.
Furthermore, scores for the Total 5-Symptom Score (T5SS) and ARIA severity scales improved beyond defined thresholds. In addition, patients highlighted specific relief from nasal obstruction and noticed better sleep quality. Similarly, asthma control (ACT) improved significantly during the observation period. However, some measures like daytime sleepiness did not reach the minimum important difference.
Although treatment satisfaction increased, the study also found that adherence levels slightly decreased over time. Thus, maintaining long-term patient engagement remains a critical factor for success. In conclusion, the ERAPP study confirms that NPP-SLIT provides sustained and meaningful relief for respiratory allergies. Consequently, doctors should consider patient expectations when designing personalized allergy care plans.
It provides sustained relief from nasal symptoms and improves sleep quality in patients with allergic rhinitis and asthma.
The Patient Benefit Index (PBI) evaluates treatment success by measuring how well a therapy fulfills a patient’s specific needs and expectations.
Yes, both age groups reported high levels of benefit, though children generally reported slightly higher fulfillment across various outcome measures.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Caimmi D et al. Patient-Perceived Benefits of Named-Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the ERAPP Real-World Cohort Study. Allergy. 2026 Mar 08. doi: 10.1111/all.70270. PMID: 41795228.
2. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2024 update.
3. Bousquet J, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4: Report of the expert panel. J Allergy Clin Immunol. 2020.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The ERAPP study reveals that NPP-SLIT provides clinically meaningful benefits for over 80% of children and adults with allergic rhinitis and asthma....
7 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
